Given the importance of SCAP/SREBP in the regulation of lipid metabolism, and its indispensable role in the pathogenesis of fatty liver, unraveling the multiple specific molecules and inhibitors targeting the SCAP/SREBP axis has become the focus of translational research (Figure 7). This evidence concerns the gene SCAP and Hepatic steatosis.